Capital International Sarl Edwards Lifesciences Corp Transaction History

Capital International Sarl

$3.14 Billion
Q2 2024

A detailed history of Capital International Sarl transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital International Sarl holds 56,855 shares of EW stock, worth $3.79 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

56,855

Previous 62,461 8.98%

Holding current value

$3.79 Million

Previous $5.97 Million 12.01%

% of portfolio

0.17%

Previous 0.21%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $472,585 - $528,701	-5,606 Reduced 8.98%	56,855 $5.25 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $1.28 Million - $1.69 Million	-17,656 Reduced 22.04%	62,461 $5.97 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $5.59 Million - $7.04 Million	-90,546 Reduced 53.06%	80,117 $6.11 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $122,972 - $165,749	-1,775 Reduced 1.03%	170,663 $11.8 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $1.19 Million - $1.38 Million	14,653 Added 9.29%	172,438 $16.3 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $4.92 Million - $5.6 Million	66,237 Added 72.35%	157,785 $13.1 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $924,782 - $1.18 Million	13,540 Added 17.36%	91,548 $6.83 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $635,237 - $827,420	7,712 Added 10.97%	78,008 $6.45 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $2.21 Million - $3.28 Million	-25,571 Reduced 26.67%	70,296 $6.68 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $243,480 - $306,475	2,388 Added 2.55%	95,867 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $4.36 Million - $5.36 Million	40,994 Added 78.11%	93,479 $12.1 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $444,777 - $530,525	-4,322 Reduced 7.61%	52,485 $5.94 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $884,092 - $1.1 Million	10,545 Added 22.79%	56,807 $5.88 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $1.23 Million - $1.42 Million	15,610 Added 50.93%	46,262 $3.87 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $425,336 - $541,267	5,933 Added 24.0%	30,652 $2.8 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $32,251 - $41,971	480 Added 1.98%	24,719 $1.97 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $935,255 - $1.25 Million	16,254 Added 203.56%	24,239 $1.68 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $691,025 - $1.07 Million	-13,185 Reduced 62.28%	7,985 $1.51 Million
Q4 2019 Feb 18, 2020	BUY	$71.7 - $82.09 $101,814 - $116,567	1,420 Added 7.19%	21,170 $4.94 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $1.22 Million - $1.49 Million	19,750 New	19,750 $4.34 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Account

Capital International Sarl Edwards Lifesciences Corp Transaction History